Literature DB >> 25945017

Usefulness of two-point Dixon fat-water separation technique in gadoxetic acid-enhanced liver magnetic resonance imaging.

Ying Ding1, Sheng-Xiang Rao1, Cai-Zhong Chen1, Ren-Chen Li1, Meng-Su Zeng1.   

Abstract

AIM: To compare differences between volumetric interpolated breath-hold examination (VIBE) using two-point Dixon fat-water separation (Dixon-VIBE) and chemically selective fat saturation (FS-VIBE) with magnetic resonance imaging examination.
METHODS: Forty-nine patients were included, who were scanned with two VIBE sequences (Dixon-VIBE and FS-VIBE) in hepatobiliary phase after gadoxetic acid administration. Subjective evaluations including sharpness of tumor, sharpness of vessels, strength and homogeneity of fat suppression, and artifacts that were scored using a 4-point scale. The liver-to-lesion contrast was also calculated and compared.
RESULTS: Dixon-VIBE with water reconstruction had significantly higher subjective scores than FS-VIBE in strength and homogeneity of fat suppression (< 0.0001) but lower scores in sharpness of tumor (P < 0.0001), sharpness of vessels (P = 0.0001), and artifacts (P = 0.034). The liver-to-lesion contrast on Dixon-VIBE images was significantly lower than that on FS-VIBE (16.6% ± 9.4% vs 23.9% ± 12.1%, P = 0.0001).
CONCLUSION: Dixon-VIBE provides stronger and more homogenous fat suppression than FS-VIBE, while has lower clarity of focal liver lesions in hepatobiliary phase after gadoxetic acid administration.

Entities:  

Keywords:  Dixon-volumetric interpolated breath-hold examination; Fat saturation-volumetric interpolated breath-hold examination; Gadoxetic acid; Magnetic resonance imaging; Volumetric interpolated breath-hold examination

Mesh:

Substances:

Year:  2015        PMID: 25945017      PMCID: PMC4408476          DOI: 10.3748/wjg.v21.i16.5017

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Dixon techniques for water and fat imaging.

Authors:  Jingfei Ma
Journal:  J Magn Reson Imaging       Date:  2008-09       Impact factor: 4.813

2.  Pelvic imaging using a T1W fat-suppressed three-dimensional dual echo Dixon technique at 3T.

Authors:  Daniel M Cornfeld; Gary Israel; Shirley M McCarthy; Jeffery C Weinreb
Journal:  J Magn Reson Imaging       Date:  2008-07       Impact factor: 4.813

3.  Band-limited contrast in natural images explains the detectability of changes in the amplitude spectra.

Authors:  D J Tolhurst; Y Tadmor
Journal:  Vision Res       Date:  1997-12       Impact factor: 1.886

4.  Simple proton spectroscopic imaging.

Authors:  W T Dixon
Journal:  Radiology       Date:  1984-10       Impact factor: 11.105

5.  Abdominal MR imaging with a volumetric interpolated breath-hold examination.

Authors:  N M Rofsky; V S Lee; G Laub; M A Pollack; G A Krinsky; D Thomasson; M M Ambrosino; J C Weinreb
Journal:  Radiology       Date:  1999-09       Impact factor: 11.105

6.  Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.

Authors:  Tomoaki Ichikawa; Kazuhiro Saito; Naoki Yoshioka; Akihiro Tanimoto; Takehiko Gokan; Yasuo Takehara; Takeshi Kamura; Toshifumi Gabata; Takamichi Murakami; Katsuyoshi Ito; Shinji Hirohashi; Akihiro Nishie; Yoko Saito; Hiroaki Onaya; Ryohei Kuwatsuru; Atsuko Morimoto; Koji Ueda; Masayo Kurauchi; Josy Breuer
Journal:  Invest Radiol       Date:  2010-03       Impact factor: 6.016

7.  Two-point Dixon technique provides robust fat suppression for multi-mouse imaging.

Authors:  Dustin K Ragan; James A Bankson
Journal:  J Magn Reson Imaging       Date:  2010-02       Impact factor: 4.813

8.  Preclinical safety evaluation of Gd-EOB-DTPA (Primovist).

Authors:  Olaf Döhr; Rainer Hofmeister; Marianne Treher; Hermann Schweinfurth
Journal:  Invest Radiol       Date:  2007-12       Impact factor: 6.016

9.  A new fully automatic and robust algorithm for fast segmentation of liver tissue and tumors from CT scans.

Authors:  Laurent Massoptier; Sergio Casciaro
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

Review 10.  MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.

Authors:  Christoph J Zech; Karin A Herrmann; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

View more
  5 in total

1.  Liver acquisition with volume acceleration flex on 70-cm wide-bore and 60-cm conventional-bore 3.0-T MRI.

Authors:  Shigeyoshi Saito; Keiko Tanaka; Takashi Hashido
Journal:  Radiol Phys Technol       Date:  2016-01-06

2.  CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?

Authors:  Leonhard Gruber; Vera Rainer; Michaela Plaikner; Christian Kremser; Werner Jaschke; Benjamin Henninger
Journal:  Eur Radiol       Date:  2017-12-20       Impact factor: 5.315

3.  Diagnostic Accuracy of Standalone T2 Dixon Sequence Compared with Conventional MRI in Sacroiliitis.

Authors:  R Athira; Seetharaman Cannane; R Thushara; Santhosh Poyyamoli; Meena Nedunchelian
Journal:  Indian J Radiol Imaging       Date:  2022-08-23

4.  Non-Invasive Electrical Impedance Tomography for Multi-Scale Detection of Liver Fat Content.

Authors:  Yuan Luo; Parinaz Abiri; Shell Zhang; Chih-Chiang Chang; Amir H Kaboodrangi; Rongsong Li; Ashish K Sahib; Alex Bui; Rajesh Kumar; Mary Woo; Zhaoping Li; René R Sevag Packard; Yu-Chong Tai; Tzung K Hsiai
Journal:  Theranostics       Date:  2018-02-08       Impact factor: 11.556

5.  Positron emission tomography-magnetic resonance liver parenchyma attenuation correction artifact in secondary hemochromatosis.

Authors:  Robert Matthews; Michael Joseph Salerno; Paul Vaska; Halley Hindman
Journal:  World J Nucl Med       Date:  2020-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.